| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Identifier | Return Reference | Explanation |
|---|---|---|
| PART I LINE 6A (990-PF) | 990-PF, PART I LINE 6A | PART I LINE 6A (990-PF) - RECONCILIATION OF NET GAIN/(LOSS) FROM SALES OF ASSETS NOT INCLUDED IN PART IV TOTAL INCLUDED IN PART IV: (DETAILS BELOW) NET GAIN/(LOSS): $468,675 TOTAL NOT INCLUDED IN PART IV: PASSTHROUGH K-1 CAPITAL GAIN/(LOSS) - UBI NET GAIN/(LOSS): $10,563 TOTAL PART I, LINE 6A: $479,238 DETAILS OF ASSETS INCLUDED IN PART IV: PUBLICLY-TRAIDED SECURITIES GROSS SALES PRICE: $5,077,406 BOOK BASIS: $4,712,054 NET GAIN/(LOSS): $365,352 PASSTHROUGH K-1 CAPITAL GAIN/(LOSS) - NON UBI NET GAIN/(LOSS): $103,323 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ISHARES NASDAQ BIOTECHNOLOGY | 170,027 | 227,235 |
| ISHARES S&P 500 INDEX FD | 364,535 | 563,085 |
| ISHARES S&P U.S. PREFERRED STO | 183,225 | 192,550 |
| ISHARES SHORT TERM CORPORATE B | 550,020 | 551,700 |
| SELECT SECTOR SPDR INDUSTRIAL | 88,901 | 132,825 |
| TECHNOLOGY SPDR | 158,350 | 325,050 |
| VANGUARD FTSE DEVELOPED MARKET | 1,175,750 | 1,298,275 |
| VANGUARD FTSE EMERGING MARKETS | 710,516 | 751,650 |
| VANGUARD GROWTH ETF | 334,623 | 380,010 |
| VANGUARD LG-CAP ETF | 1,839,367 | 3,866,280 |
| VANGUARD MID-CAP ETF | 882,162 | 1,654,160 |
| VANGUARD SM-CAP ETF | 695,128 | 876,060 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INTERNATIONAL FARMLAND FUND | 480,500 | 386,846 | |
| PROVIDENCE VII PARTICIPATION | 251,439 | 338,825 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative Fees | 39,783 | 39,783 | ||
| K-1 Exp PROVIDENCE VII PARTICI | 9,929 | 9,353 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| K-1 Inc/Loss PROVIDENCE VII PARTICIPATION TRUST | -1,849 | -1,892 | |
| Class Action Lawsuit Proceeds | 21 | 21 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Investment Management Services | 67,839 | 67,839 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF Estimated Tax for 2020 | 4,300 | |||
| 990-PF Excise Tax for 2019 | 710 | |||
| 990-PF Extension for 2019 | 211 | |||
| 990-T Extension for 2019 | 300 | |||
| IRS MISCELLANEOUS FEE | 13 | |||
| STATE INCOME TAX 2019 | 250 |